Rchr
J-GLOBAL ID:201601021228389863   Update date: Aug. 08, 2024

Murakami Ryusuke

ムラカミ リュウスケ | Murakami Ryusuke
Affiliation and department:
Research field  (2): Obstetrics and gynecology ,  Clinical pharmacy
Research keywords  (4): pathology ,  artificial intelligence ,  bioinformatics ,  ovarian cancer
Research theme for competitive and other funds  (13):
  • 2022 - 2025 難治性卵巣癌に対する、抗VEGF抗体とB7H3を標的とした併用療法の開発
  • 2021 - 2025 Novel diagnostic and therapeutic strategies for ovarian cancer by investigation of cancer and host diversity
  • 2018 - 2023 Development of new treatment for ovarian cancer based on intratumor heterogeneity
  • 2020 - 2022 Therapeutic development targeting B7H3 in the tumor microenvironment of ovarian cancer
  • 2018 - 2022 Development of tumor-host integrative therapies to overcome the refractory nature of uterine serous carcinoma
Show all
Papers (59):
  • Akihiko Ueda, Hidekatsu Nakai, Chiho Miyagawa, Tomoyuki Otani, Manabu Yoshida, Ryusuke Murakami, Shinichi Komiyama, Terumi Tanigawa, Takeshi Yokoi, Hirokuni Takano, et al. Artificial Intelligence-Based Histopathological Subtyping of High-Grade Serous Ovarian Cancer. The American journal of pathology. 2024
  • Saya Tamura, Koji Yamanoi, Yoshihide Inayama, Yasuhisa Kurata, Yuki Himoto, Mana Taki, Ryusuke Murakami, Akihito Horie, Ken Yamaguchi, Junzo Hamanishi, et al. Investigation of the clinical implications of anterior cervical invasion in locally advanced cervical squamous cell carcinoma. The journal of obstetrics and gynaecology research. 2024
  • Yoko Furutake, Ken Yamaguchi, Koji Yamanoi, Sachiko Kitamura, Shiro Takamatsu, Mana Taki, Masayo Ukita, Yuko Hosoe, Ryusuke Murakami, Kaoru Abiko, et al. YAP1 suppression by ZDHHC7 is associated with ferroptosis resistance and poor prognosis in ovarian clear cell carcinoma. Molecular cancer therapeutics. 2024
  • Kohei Hamada, Ryusuke Murakami, Akihiko Ueda, Yoko Kashima, Chiho Miyagawa, Mana Taki, Koji Yamanoi, Ken Yamaguchi, Junzo Hamanishi, Sachiko Minamiguchi, et al. A Deep Learning-Based Assessment Pipeline for Intraepithelial and Stromal Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Carcinoma. The American journal of pathology. 2024. 194. 7. 1272-1284
  • Maya Komatsu, Yoshitsugu Chigusa, Ryusuke Murakami, Masahito Takakura, Masaki Mandai, Haruta Mogami. X-ray Pelvimetry Has No Impact on the Outcomes of Trial of Labor after Cesarean Delivery: A Retrospective Single-center Study. The Kobe journal of medical sciences. 2024. 70. 2. E70-E76
more...
Books (4):
  • 産婦人科領域(別冊 BIO Clinica 慢性炎症と疾患 通巻32号 第13巻第1巻)
    北隆館 2024
  • 明日からできる卵巣がん手術
    メジカルビュー社 2022 ISBN:9784758319928
  • 新臨床腫瘍学(改訂第5版): がん薬物療法専門医のために
    南江堂 2018 ISBN:4524237887
  • 産科・婦人科の手術看護パーフェクトマニュアル
    メディカ出版 2018 ISBN:9784840465328
Lectures and oral presentations  (11):
  • 卵巣癌の”プラチナ抵抗性を見据えた治療選択”を考察する
    (第9回日本産科婦人科遺伝診療学会学術講演会 2024)
  • ロボット手術教育にVirtual Reality (VR)の応用する試み〜3D技術で安全性と精度 向上を目指す
    (第66 回日本婦人科腫瘍学会学術講演会 2024)
  • Virtual Realityと追いトレアドバンスを用いた ロボット手術教育の試み
    (第12回日本婦人科ロボット手術学会 2024)
  • The Artificial Intelligence Shedding Light on Tumor Microenvironment in High Grade Serous Ovarian Carcinoma
    (AOFOG 2024 2024)
  • 卵巣癌治療の個別化 ~プラチナ抵抗性になってからの治療選択の考え方~
    (婦人科がん患者のトータルケア 2023)
more...
Education (2):
  • 2012 - 2016 Kyoto University Graduate School of Medicine Department of Gynecology and Obstetrics
  • 1997 - 2003 Hiroshima University Faculty of Medicine
Work history (5):
  • 2022/04 - 現在 京都大学大学院医学研究科 婦人科学・産科学分野 助教
  • 2019/03 - 2022/02 滋賀県立総合病院 産婦人科 医長
  • 2016/07 - 2019/03 京都大学医学部附属病院 産科婦人科 特定病院助教
  • 2016/04 - 2016/06 京都大学医学部附属病院 産科婦人科 医員
  • 2011/10 - 2012/03 京都大学医学部附属病院 産科婦人科 医員
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page